Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021711

Expand all

ABLAVAR (GADOFOSVESET TRISODIUM)
2440MG/10ML (244MG/ML) Marketing Status: Discontinued

Active Ingredient: GADOFOSVESET TRISODIUM
Proprietary Name: ABLAVAR
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 2440MG/10ML (244MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021711
Product Number: 001
Approval Date: Dec 22, 2008
Applicant Holder Full Name: LANTHEUS MEDICAL IMAGING INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

ABLAVAR (GADOFOSVESET TRISODIUM)
3660MG/15ML (244MG/ML) Marketing Status: Discontinued

Active Ingredient: GADOFOSVESET TRISODIUM
Proprietary Name: ABLAVAR
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 3660MG/15ML (244MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021711
Product Number: 002
Approval Date: Dec 22, 2008
Applicant Holder Full Name: LANTHEUS MEDICAL IMAGING INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English